These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 1018985

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Neuro-ophthalmologic accidents caused by hormonal contraception].
    Ardouin M, Urvoy M, Lavenant F.
    Bull Mem Soc Fr Ophtalmol; 1978; 90():261-7. PubMed ID: 750008
    [Abstract] [Full Text] [Related]

  • 4. [Thrombotic complications of the hormonal contraceptive method].
    Beaumont JL, Beaumont V, Fontaine C, Jan F, Buxtorf JC.
    Ann Med Interne (Paris); 1978; 127(8-9):600-6. PubMed ID: 1008385
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The pill and thromboembolism. 1. Thrombogenesis and additional risk factors. A review of the literature].
    Herzog C, Mall-Haefeli M.
    Ther Ggw; 1979 Oct; 118(10):1550-74. PubMed ID: 386549
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Oral contraceptives: cardiovascular complications and additional risk factors (author's transl)].
    Herzog C.
    Schweiz Rundsch Med Prax; 1979 Oct 09; 68(41):1321-9. PubMed ID: 394143
    [No Abstract] [Full Text] [Related]

  • 11. [Venous thrombosis of the upper extremity after hormonal contraception].
    Kohoutek M, Chalupa M.
    Cesk Gynekol; 1981 May 09; 46(4):302-6. PubMed ID: 7249100
    [Abstract] [Full Text] [Related]

  • 12. The pill revisited.
    Connell EB.
    Fam Plann Perspect; 1975 May 09; 7(2):62-71. PubMed ID: 1092557
    [No Abstract] [Full Text] [Related]

  • 13. [The importance of risk factors in cerebrovascular processes while taking oral contraceptives (author's transl)].
    Holtmann W, Berger G.
    MMW Munch Med Wochenschr; 1977 Dec 02; 119(48):1557-60. PubMed ID: 414098
    [Abstract] [Full Text] [Related]

  • 14. [Ovulation inhibitors from a neurological viewpoint].
    Gschwend J.
    Schweiz Med Wochenschr; 1976 May 02; 106(19):644-7. PubMed ID: 996486
    [Abstract] [Full Text] [Related]

  • 15. [Incidence of cerebrovascular lesions in users of oral contraceptives].
    Borovská D, Volejník V.
    Cesk Neurol Neurochir; 1981 Mar 02; 44(2):116-20. PubMed ID: 7237632
    [Abstract] [Full Text] [Related]

  • 16. [Incidence of arterial hypertension in women taking oral hormonal contraceptive agents (femigen)].
    Mikrut W.
    Wiad Lek; 1983 Oct 01; 36(19):1587-92. PubMed ID: 6198806
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Paget-Schroetter syndrome caused by the use of oral contraceptives].
    Steiner A, Millei J, Ján H, Erös L.
    Orv Hetil; 1982 Sep 26; 123(39):2419-21. PubMed ID: 7145407
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Real and false risks of hormonal contraceptives].
    Belaïsch J.
    Gynakol Rundsch; 1984 Sep 26; 24 Suppl 1():12-9. PubMed ID: 6519541
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.